TransCode Therapeutics Inc. Made Headway
Wed, Dec 07, 2022 at 07:00 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $0.98, a gain of 133.4%. On Wed, Dec 07, 2022, RNAZ:NASDAQ hit a New 2-Week High of $0.98. The stock got featured on our News Catalysts scanner on Wed, Dec 07, 2022 at 05:27 PM in the 'BIOTECH' category. From Wed, Nov 23, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Oct 26, 2022 at $1.55 with a volume of 34M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Ignyta, Inc. (RXDX:NASDAQ), 165.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 133.44%
- FLJ Group Limited (FLJ:NASDAQ), 57.3%
- Vor Biopharma Inc. (VOR:NASDAQ), 41.86%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 37.16%
- Summit Therapeutics plc (SMMT:NASDAQ), 33.33%
- NexGel Inc (NXGL:NASDAQ), 28.33%
- Eargo Inc. (EAR:NASDAQ), 27.48%
- Bit Brother Limited (BTB:NASDAQ), 23.65%
- MongoDB, Inc. (MDB:NASDAQ), 23.23%